Reference
Abogunrin S, et al. Budget impact analysis of botulinum toxin A therapy for upper limb spasticity in the United Kingdom. ClinicoEconomics and Outcomes Research : 1 Apr 2015. Available from: URL: http://dx.doi.org/10.2147/CEOR.S76141
Rights and permissions
About this article
Cite this article
BoNT-A therapy for ULS saves costs in the UK. PharmacoEcon Outcomes News 726, 9 (2015). https://doi.org/10.1007/s40274-015-2057-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-015-2057-2